Trial
NCT03053284
Pasireotide in Hyperinsulinemic Hypoglycemia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Montefiore Medical Center
Collaborators
Novartis Pharmaceuticals
Condition
Congenital Hyperinsulinism
Intervention
Pasireotide 0.6Mg Solution for Injection
Why stopped
Funding was withdrawn by Sponsor prior to start of study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-14